Filter
1275
Filtered Results: 1275
Text search:
molecular
testing
Featured
Recommendations
168
New Publications
271
Language
Document type
No document type
612
Guidelines
265
Studies & Reports
220
Manuals
68
Strategic & Response Plan
55
Fact sheets
27
Training Material
14
Situation Updates
9
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
80
Western and Central Europe
44
Global
40
Latin America and the Carribbean
33
Africa
29
Kenya
28
Eastern Europe
24
Tanzania
23
South Africa
22
Ethiopia
20
Brazil
18
Germany
17
Nigeria
14
West and Central Africa
14
East and Southern Africa
14
Sierra Leone
13
Malawi
12
Rwanda
11
South–East Asia Region
11
Uganda
11
Russia
11
Philippines
10
Colombia
9
Peru
9
Zambia
9
Indonesia
9
Liberia
9
Nepal
8
Zimbabwe
8
Asia
8
Namibia
8
Mozambique
7
Congo, Democratic Republic of
7
Argentina
7
Bangladesh
6
Myanmar / Burma
6
Ukraine
5
Ghana
5
Syria
5
Senegal
5
USA
5
Middle East and North Africa
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Angola
5
Burkina Faso
4
Ecuador
4
El Salvador
3
Chile
3
Cambodia
3
Guinea-Bissau
3
Spain
3
Lebanon
3
Vietnam
3
Botswana
3
South Sudan
3
Eswatini/ Swaziland
3
Pakistan
3
Tajikistan
2
Lesotho
2
Turkey
2
Benin
2
Cameroon
2
Guinea
2
Italy
2
Venezuela
2
Bolivia
2
Georgia
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
Gambia
1
Afghanistan
1
Haiti
1
Dominican Republic
1
Jordan
1
North America
1
Gabon
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Nicaragua
1
Palestine
1
Honduras
1
Iraq
1
Somalia
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Guidelines
126
Policies & Guidelines HIV & TB
99
COVID-19
86
Studies & Reports
73
Policies
44
TB
44
Drugs & Medical Equipment
35
Disease Prevention & Control
25
Women & Child Health
22
Capacity Building
20
Virology
18
Pediatrics
17
Malaria
17
General Guidelines
12
Statistics
12
Non-communicable Diseases
12
HIV & STI
12
Bacteriology
11
Communicable Diseases
10
Hepatitis
10
Vaccine-preventable Diseases
10
Countries
10
Parasitology
9
Paediatrics
8
NTDs & Others
8
Yellow Fever
7
Vector Control
6
Dengue
6
Cancer
5
Monitoring & Evaluation
5
MPOX - Monkeypox
5
Rabies
4
Diabetes
4
Cancer Treatment & Resources
4
Infection Control & Prevention (IPC)
4
Snakebites
4
Chagas
4
Hemorrhagic Fever
4
Diarrhoeal Disease/Cholera
4
Medical Devices & Equipment
4
Community Health
4
Quality Control & Assurance
4
Leishmaniasis
4
Water
4
Public Health
3
Yaws
3
Cervical Cancer
3
Breast Cancer
3
Public Health
3
NCD
3
Cardiovascular Diseases
3
Clinical Guidelines
3
Demograhic Health Surveys DHS
3
Humanitarian Crisis
3
Immunization
3
Surgery & Anaesthesia
3
General Guidelines
3
Communicable Diseases
3
Gynaecology & Obstetrics
3
Health Systems
3
Women & Child Health
3
Maternal Health
3
Laboratory Quality Assurance
3
Reproductive Health
3
Zika
2
Pharmacy & Technology
2
Hand Hygiene
2
Community Health
2
Yersinia pestis (Plague)
2
Information, Education and Communication (IEC)
2
Other
2
Respiratory Infections
2
Needs Assessment
2
Key Resources
2
Food Security & Nutrition
2
Dental & Eye Care
1
Child Health
1
Buruli Ulcer
1
Disaster Preparedness
1
Schistosomiasis
1
Other Cancer diseases
1
Palliative Care
1
Mental Health
1
COPD/Asthma
1
Leprosy
1
Protection & Security
1
Laboratory Technologies
1
Age & Elderly
1
Radiology and Diagnostic
1
Toolboxes
Country specific documents
48
Diagnostics & Laboratory Guidance
45
Detection & Diagnosis
43
Country specific
36
Clinical Guidelines
32
Prevention & Control
30
Drug resistant TB
27
Adults
20
TB/HIV Coinfection
17
Surveillance & Contact tracing
16
TB & Prisoners
15
Children/Adolescents Mental Disorders
14
Surveillance
13
International
12
Reports & Studies
12
Public Health
11
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
11
Children
11
Reports
11
Prevention & Preparedness
11
Testing Guidelines
11
HIV testing & services
10
Children & Adolescents
10
Laboratory
10
Studies
10
General
10
Infection Control General
10
Essential Medicines & Devices Lists
10
Eastern Europe & Central Asia
10
SEAR (South-east Asia Region)
10
Surveillance
9
Influenza Prevention & Control
9
General
9
Laboratory
9
Genomic sequencing
9
Disease Prevention & Control
9
Research & Access
9
Clinical Aspects, Treatment & Prevention
8
TB & Other Vulnerable Populations
8
Context & Facts, Travel Advice
8
Essential Medicines & Medical Devices
8
Eastern Europe and central Asia
8
Policies & Strategies
7
Childhood TB
7
Laboratory Guidance
7
Agriculture & Veterinary
7
Clinical Aspects
7
Research
7
Global Impact: Socio-economic, health services, TB & HIV
7
SARS-CoV-2 Variants
7
General documents One Health
7
Clinical Aspects & Diagnostics
7
TB
7
Treatment & Prevention
6
Opportunistic Infections
6
Laboratory & Sampling
6
Treatment Guidelines
6
TB/COVID-19
6
Advocacy & Communication
6
Clinical Aspects & Diagnostics
6
Overview, Studies & Reports
6
Policies and guidelines
6
Training
6
Germany
6
Assessment & Studies
5
ART Drug Resistance
5
IPC
5
Vaccines & Immunization
5
Yellow Fever Prevention & Control
5
Clinical Guidelines
5
Country Specific
5
Appeals and Response Plans
5
Hospital Readiness/Essential Health Services
5
Long COVID/ Post-COVID Syndrome
5
Colombia
5
Essential Medicines
5
Falsified & Substandard
5
Zoonoses
5
MPOX - Monkeypox
5
Studies & Reports
5
Access to treatment and laboratory
5
General
5
Neurological Disorders
5
Assessment
5
Clinical Guidelines
5
Antiretroviral Treatment ART
5
Kenya
5
Outbreak Prevention & Control
4
Ebola Prevention & Control
4
Influenza
4
Surveillance
4
HIV
4
TB
4
Ethiopia
4
Context & Facts
4
For Health Worker
4
Paediatrics
4
Access & Strategy
4
Rational use of Medicine
4
MPOX - Monkeypox
4
Chagas
4
Clinical Aspects & Diagnostics
4
Studies & Reports
4
Studies & Reports
4
Dengue Prevention & Control
4
Latin America & the Carribean
4
HIV and coinfection
4
Chikungunya Prevention & Control
4
AmR (Region of Americas)
4
Preparedness & Prevention
4
Gynaecology / Obstetrics
3
Meningitis Prevention & Control
3
Moldova
3
Azerbaijan
3
Yellow Fever
3
Preparedness, Response & Risk Communication
3
Hepatitis
3
Treatment Guidelines HIV
3
Namibia
3
Stroke
3
Vaccination
3
Georgia
3
Drug resistance
3
Russia
3
Supporting tools
3
Infection Prevention & Hygiene
3
Clinical Aspects
3
Public Health
3
For Pregnant Women
3
Training, others
3
Scientific & Research Studies
3
Gender Aspects
3
Oxygen Therapy
3
Non-pharmaceutical interventions (NPIs)
3
TB/HIV
3
Quality Assurance
3
Traditional & Herbal Medicines
3
HIV &TB
3
Antimicrobial Resistance (AMR)
3
Clinical Aspects & Diagnostics
3
Studies & Reports
3
Studies & Reports
3
Yaws & other Endemic Treponematoses
3
Studies & Reports
3
General
3
Tuberculosis
3
Nigeria
3
Zika Prevention & Control
3
Western & Central Europe
3
Preparedness & Prevention
3
Laboratory & Diagnostics
3
Public Health
3
Neurological disorders, Others
3
Biosafety
2
Clinical Guidelines
2
Chemical Attacks
2
Policies & Strategies
2
Hand Hygiene
2
Vector Control
2
Ukraine
2
South Africa
2
WPRO (Western Pacific Region)
2
Prevention Guidelines
2
Measures ICF/ Model Disability Survey
2
Eastern Mediterranean Region
2
National Policies
2
Communication & Training
2
Drug resistance
2
Tools for Rational use
2
Prophylaxis
2
Preparedness, Response & Risk Communication
2
Standard Precautions
2
Clinical aspects
2
Attention deficit hyperactivity disorder (ADHD)
2
Country Guidelines
2
Health Personnel
2
Essential List
2
Prison & Detention
2
For Older People
2
Educational Settings
2
Physical Distancing
2
Situation Reports COVID-19
2
Vaccine Candidates & Research
2
Immunization Guidelines
2
Long-term Care Facilities
2
Preparedness, Response & Risk Communication
2
Logistics & Supply
2
COVAX Initiative
2
Vaxzevria (Astra Zeneca)
2
Overview
2
Biodiversity shift
2
Climate Change General
2
Agriculture
2
Pharmacy Practice
2
One Health
2
Argentina
2
General Guidelines for Rational Use
2
Pharmacovigilance
2
Health Care Systems
2
Prevention & Measures
2
Infectious Diseases
2
MPOX -Monkeybox Prevention & Control
2
Leishmaniasis
2
Statistics & Facts
2
Statistics & Facts
2
Leptospirosis
2
Snakebite envenoming
2
General Information & Methodology
2
Health Financing Toolbox
2
Clinical Aspects & Diagnosis
2
Women
2
Prevention & Strategies
2
Clinical Guidelines
2
Co-Morbidities (except TB)
2
Autism
2
Technical Information
2
Substance Use Disorders & Addiction
2
Malawi
2
TB/HIV Global
2
Education of students & professionals
2
Nutrition
2
Prevention of mother-to-child transmission (PMTCT)
2
Uganda
2
Paediatrics
2
Infection Control
2
Context & Facts
2
HIV in Key Populations
2
Action Plans, Policies & Response
2
Public Health
2
Plague Prevention & Control
2
War & Conflict
1
Drugs
1
Rapid Response
1
Natural Disaster
1
Health Systems
1
Treatment Guidelines
1
Psychosocial Support (MHPSS)
1
Behaviour Change/Life Skill Education
1
Intellectual Disability
1
General Reports
1
TB & Drug Abuse
1
Children with Disabilities
1
Posttraumatic stress disorder Adults
1
Training
1
Guillain-Barré Syndrome
1
HIV surveillance
1
Pediatrics
1
Zambia
1
Plague
1
Neuropsychology of Trauma
1
Training Manuals
1
Substance Use Disorders, Others
1
Context, Facts & Travel Advice
1
Children
1
Social Mobilisation
1
Dengue
1
Policies
1
Infection Control
1
Platforms and initiatives
1
General Mental Health Guidelines
1
Eastern Europe
1
General Studies & Reports
1
Cholera Prevention & Control
1
Global
1
Training Material
1
People who injecting Drugs
1
Rwanda
1
SOPs
1
African Region
1
Mozambique
1
Ebola
1
Public Health
1
Child Health / Pediatrics
1
Microcephaly
1
Training
1
Workplace
1
Manual & Leaflet
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Sustainable Development Goals
1
Sex Worker
1
Clinical Guidelines
1
Cannabis
1
Situation Reports & Updates
1
Best Practice
1
Hand Hygiene
1
PPE Personel Protective Equipment
1
Covid-19 & the One Health Approach
1
COVID-19
1
For Parents & Children
1
For Migrants & Refugees
1
Simulations
1
Sustainability
1
Child Protection
1
HIV and COVID-19
1
Infection Control & Prevention (IPC)
1
Blood Supply
1
Latin America
1
Community Health
1
Environmental NPIs
1
Ebola Treatment Center
1
Psychosocial Support
1
Fair Allocation & Ethical Aspects
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Research & Pipeline
1
Hand Hygiene
1
Studies & Reports
1
Palliative Care
1
Estonia
1
Latin America
1
Peru
1
Booster Doses
1
Ecuador
1
Planetary Health
1
Reports
1
Food environments
1
Overview & reports
1
Mobility
1
Model Formulary
1
Cancer
1
Intensive Care Unit
1
Guiding documents and principles
1
Agriculture incl. animal husbandry
1
Waste Managment
1
Public Health
1
Non-communicable Diseases NCD
1
WASH Water Sanitation & Hygiene
1
Water Pollution
1
Health Impact & Climate Change
1
Nuclear & Chemical Hazards
1
Health Care In Conflict Settings
1
Dengue & Chikungunya
1
Strategies & Roadmaps
1
Capacity Building & Resources
1
Information & Education Material (IEC)
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Echinocccosis
1
Onchocerciasis
1
Taeniasis/Cysticercosis
1
Education
1
General Information
1
Prevention & Strategies
1
Statistics & Facts
1
Studies & Reports
1
Armenia
1
Clinical Aspects & Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Romania
1
Asia and Pacific
1
General
1
others
1
Alzheimer's Disease & Dementia
1
Ghana
1
General Aspects
1
Bipolar Affective Disorders
1
Regional Reports & Guidelines, others
1
One Health
1
Policy
1
Asia
1
Prophylactic Treatment
1
Diarrhoea
1
AR (African Region)
1
Technical Information
1
Technical Information
1
Reproductive Health
1
Vision Loss & Blindness
1
Clinical Guidelines
1
International
1
Situation Reports
1
Travel Medicine
1
Others
1
Tajikistan
1
HIV service delivery
1
Kazakhstan
1
MHPSS Guidelines
1
Learning Disabilities
1
South-east Asia Region
1
Laboratory
1
Marburg Virus Situation Reports
1
Epidemiology
1
Chikungunya
1
Case Definitions
1
Situation Reports, others
1
Key Resources
1
AMR
1
Meningitis & Encephalitis
1
Situation Reports & Updates
1
Treatment & Clinical Management
1
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Los coronavirus son un grupo de virus ARN altamente diversos de la familia Coronaviridae que se dividen en
4 géneros: alfa, beta, gamma y delta, y que causan enfermedades de leves a graves en humanos y animales
(1-3). Existen coronavirus humanos endémicos como los alfacoronavirus 229E y NL63 y l...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
First Global Patient Safety Challenge Clean Care is Safer Care
The WHO Guidelines on Hand Hygiene in Health Care provide health-care workers (HCWs), hospital administrators and health authorities with a thorough review of evidence on hand hygiene in health care and specific recommendations to impro...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
A total of 18 laboratories from 13 countries participated in the four rounds of EQA: 10 laboratories from eight African endemic countries, four of which participated in all four rounds and three in three rounds. The overall results showed that the median performance of these laboratories improved ov...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
Training module on malaria control
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-level data of acute hepatitis of unknown aetiology.
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...
